BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 35213358)

  • 1. An integrated tumor, immune and microbiome atlas of colon cancer.
    Roelands J; Kuppen PJK; Ahmed EI; Mall R; Masoodi T; Singh P; Monaco G; Raynaud C; de Miranda NFCC; Ferraro L; Carneiro-Lobo TC; Syed N; Rawat A; Awad A; Decock J; Mifsud W; Miller LD; Sherif S; Mohamed MG; Rinchai D; Van den Eynde M; Sayaman RW; Ziv E; Bertucci F; Petkar MA; Lorenz S; Mathew LS; Wang K; Murugesan S; Chaussabel D; Vahrmeijer AL; Wang E; Ceccarelli A; Fakhro KA; Zoppoli G; Ballestrero A; Tollenaar RAEM; Marincola FM; Galon J; Khodor SA; Ceccarelli M; Hendrickx W; Bedognetti D
    Nat Med; 2023 May; 29(5):1273-1286. PubMed ID: 37202560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed Effects Machine Learning Models for Colon Cancer Metastasis Prediction using Spatially Localized Immuno-Oncology Markers.
    Levy JJ; Bobak CA; Nasir-Moin M; Veziroglu EM; Palisoul SM; Barney RE; Salas LA; Christensen BC; Tsongalis GJ; Vaickus LJ
    Pac Symp Biocomput; 2022; 27():175-186. PubMed ID: 34890147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanylate binding protein 5 accelerates gastric cancer progression via the
    Cao FY; Wang CH; Li X; Ma MZ; Tao GC; Yang C; Li K; He XB; Tong SL; Zhao QC; Su S; Song D; Zheng YB
    Am J Cancer Res; 2023; 13(4):1310-1328. PubMed ID: 37168340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy response.
    Li X; Song D; Su S; He X; Cao F; Yang C; Li K; Huang S; Li C; Wang C; Zhang A; Pang P; Zheng Y
    Front Genet; 2022; 13():984615. PubMed ID: 36246628
    [No Abstract]   [Full Text] [Related]  

  • 5. Intratumor APOL3 delineates a distinctive immunogenic ferroptosis subset with prognosis prediction in colorectal cancer.
    Lv Y; Zheng P; Mao Y; Xu Y; Chang W; Lin Q; Ji M; Ye L; Tang W; Xu J
    Cancer Sci; 2024 Jan; 115(1):257-269. PubMed ID: 37986654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC.
    Fan H; Shi Y; Wang H; Li Y; Mei J; Xu J; Liu C
    Int J Gen Med; 2023; 16():1757-1769. PubMed ID: 37193249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advancements, Limitations, and Future Perspectives of the use of Personalized Medicine in Treatment of Colon Cancer.
    Dey A; Mitra A; Pathak S; Prasad S; Zhang AS; Zhang H; Sun XF; Banerjee A
    Technol Cancer Res Treat; 2023; 22():15330338231178403. PubMed ID: 37248615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-OMICs data analysis identifies molecular features correlating with tumor immunity in colon cancer.
    Elsayed I; Elsayed N; Feng Q; Sheahan K; Moran B; Wang X
    Cancer Biomark; 2022; 33(2):261-271. PubMed ID: 35213358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of molecular features correlating with tumor immunity in gastric cancer by multi-omics data analysis.
    He Y; Wang X
    Ann Transl Med; 2020 Sep; 8(17):1050. PubMed ID: 33145269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data.
    Li M; Gao X; Wang X
    Front Immunol; 2023; 14():1090838. PubMed ID: 36911742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APC mutation correlated with poor response of immunotherapy in colon cancer.
    Li B; Zhang G; Xu X
    BMC Gastroenterol; 2023 Mar; 23(1):95. PubMed ID: 36977982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
    Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
    Front Immunol; 2021; 12():665002. PubMed ID: 34367132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying tumor immunity-associated molecular features in liver hepatocellular carcinoma by multi-omics analysis.
    Shen Q; He Y; Qian J; Wang X
    Front Mol Biosci; 2022; 9():960457. PubMed ID: 36339710
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.